{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T10:23:33Z","timestamp":1791887013131,"version":"4.3.4"},"reference-count":61,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["1R01EY022120-01A1"],"award-info":[{"award-number":["1R01EY022120-01A1"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Institute of General Medical Sciences, National Institutes of Health","award":["P20GM104932"],"award-info":[{"award-number":["P20GM104932"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Pharmaceutics"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.ijpharm.2017.06.042","type":"journal-article","created":{"date-parts":[[2017,6,20]],"date-time":"2017-06-20T04:16:50Z","timestamp":1497932210000},"page":"32-43","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":67,"title":["Ocular disposition of ciprofloxacin from topical, PEGylated nanostructured lipid carriers: Effect of molecular weight and density of poly (ethylene) glycol"],"prefix":"10.1016","volume":"529","author":[{"given":"Sai Prachetan","family":"Balguri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Goutham R.","family":"Adelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karthik Yadav","family":"Janga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prakash","family":"Bhagav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soumyajit","family":"Majumdar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"13","key":"10.1016\/j.ijpharm.2017.06.042_bib0005","first-page":"463","article-title":"Development and evaluation of prolonged release topical indomethacin formulations for ocular inflammation","volume":"55","author":"Adelli","year":"2014","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"5","key":"10.1016\/j.ijpharm.2017.06.042_bib0010","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1208\/s12249-015-0315-z","article-title":"Effect of cyclodextrins on morphology and barrier characteristics of isolated rabbit corneas","volume":"16","author":"Adelli","year":"2015","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ijpharm.2017.06.042_bib0015","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.ejpb.2015.02.006","article-title":"Evaluation of topical hesperetin matrix film for back-of-the-eye delivery","volume":"92","author":"Adelli","year":"2015","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"1","key":"10.1016\/j.ijpharm.2017.06.042_bib0020","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1080\/10717544.2016.1256000","article-title":"Diclofenac sodium ion exchange resin complex loaded melt cast films for sustained release ocular delivery","volume":"24","author":"Adelli","year":"2017","journal-title":"Drug Deliv."},{"issue":"1","key":"10.1016\/j.ijpharm.2017.06.042_bib0025","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0005-2736(91)90246-5","article-title":"Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo","volume":"1066","author":"Allen","year":"1991","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ijpharm.2017.06.042_bib0030","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.jcis.2013.02.030","article-title":"A comparative study of submicron particle sizing platforms: accuracy, precision and resolution analysis of polydisperse particle size distributions","volume":"405","author":"Anderson","year":"2013","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.ijpharm.2017.06.042_bib0035","series-title":"Guidance for Industry Bioanalytical Method Validation","author":"Anon","year":"2013"},{"issue":"7","key":"10.1016\/j.ijpharm.2017.06.042_bib0040","first-page":"2269-","article-title":"Development of nano structured lipid carriers of ciprofloxacin for ocular delivery: characterization, in vivo distribution and effect of PEGylation","volume":"56","author":"Balguri","year":"2015","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ijpharm.2017.06.042_bib0045","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.ejpb.2016.10.015","article-title":"Topical ophthalmic lipid nanoparticle formulations (SLN NLC) of indomethacin for delivery to the posterior segment ocular tissues","volume":"109","author":"Balguri","year":"2016","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"1","key":"10.1016\/j.ijpharm.2017.06.042_bib0050","doi-asserted-by":"crossref","first-page":"49","DOI":"10.15171\/bi.2016.07","article-title":"Advanced drug delivery and targeting technologies for the ocular diseases","volume":"6","author":"Barar","year":"2016","journal-title":"Bioimpacts"},{"issue":"2","key":"10.1016\/j.ijpharm.2017.06.042_bib0055","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jconrel.2012.03.020","article-title":"Doxil\u00ae \u2014 the first FDA-approved nano-drug: lessons learned","volume":"160","author":"Barenholz","year":"2012","journal-title":"J. Control. Release"},{"issue":"11","key":"10.1016\/j.ijpharm.2017.06.042_bib0060","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1124\/dmd.113.052704","article-title":"Expression of efflux transporters in human ocular tissues","volume":"41","author":"Chen","year":"2013","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ijpharm.2017.06.042_bib0065","first-page":"815981","article-title":"Cubic and hexagonal liquid crystals as drug delivery systems","volume":"2014","author":"Chen","year":"2014","journal-title":"BioMed Res. Int."},{"issue":"2","key":"10.1016\/j.ijpharm.2017.06.042_bib0070","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1089\/jop.2012.0200","article-title":"Novel strategies for anterior segment ocular drug delivery","volume":"29","author":"Cholkar","year":"2013","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.ijpharm.2017.06.042_bib0075","first-page":"279","article-title":"Intracellular trafficking of hyaluronic acid-chitosan oligomer-based nanoparticles in cultured human ocular surface cells","volume":"17","author":"Contreras-Ruiz","year":"2011","journal-title":"Mol. Vis."},{"issue":"1","key":"10.1016\/j.ijpharm.2017.06.042_bib0080","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0928-0987(03)00178-7","article-title":"The effect of a PEG versus a chitosan coating on the interaction of drug colloidal carriers with the ocular mucosa","volume":"20","author":"De Campos","year":"2003","journal-title":"Eur. J. Pharm. Sci."},{"issue":"3","key":"10.1016\/j.ijpharm.2017.06.042_bib0085","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/1520-6017(200103)90:3<288::AID-JPS4>3.0.CO;2-5","article-title":"Ocular tolerability and in vivo bioavailability of poly(ethylene glycol) (PEG)-coated polyethyl-2-cyanoacrylate nanosphere-encapsulated acyclovir","volume":"90","author":"Fresta","year":"2001","journal-title":"J. Pharm. Sci."},{"issue":"3","key":"10.1016\/j.ijpharm.2017.06.042_bib0090","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1208\/s12248-010-9183-3","article-title":"Ocular drug delivery","volume":"12","author":"Gaudana","year":"2010","journal-title":"AAPS J."},{"issue":"5","key":"10.1016\/j.ijpharm.2017.06.042_bib0095","first-page":"961","article-title":"Drug delivery for posterior segment eye disease","volume":"41","author":"Geroski","year":"2000","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"4","key":"10.1016\/j.ijpharm.2017.06.042_bib0100","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1023\/A:1023290514575","article-title":"Influence of preparation conditions on acyclovir-loaded poly-d,l-lactic acid nanospheres and effect of PEG coating on ocular drug bioavailability","volume":"20","author":"Giannavola","year":"2003","journal-title":"Pharm. Res."},{"issue":"13","key":"10.1016\/j.ijpharm.2017.06.042_bib0105","doi-asserted-by":"crossref","first-page":"3657","DOI":"10.1016\/j.biomaterials.2010.01.065","article-title":"Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles","volume":"31","author":"He","year":"2010","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.ijpharm.2017.06.042_bib0110","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1208\/s12249-009-9373-4","article-title":"Ciprofloxacin as ocular liposomal hydrogel","volume":"11","author":"Hosny","year":"2010","journal-title":"AAPS PharmSciTech."},{"key":"10.1016\/j.ijpharm.2017.06.042_bib0115","unstructured":"P.K. Hui, W.R. Diluzio, Stabilization and terminal sterilization of phospholipid formulations Google Patents; 2002."},{"issue":"4","key":"10.1016\/j.ijpharm.2017.06.042_bib0120","first-page":"19","article-title":"Bioanalytical method development and validation of ciprofloxacin by RP-HPLC method","volume":"2","author":"Hussain","year":"2012","journal-title":"Asian J. Pharm. Biol. Res."},{"issue":"1","key":"10.1016\/j.ijpharm.2017.06.042_bib0125","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.ijpharm.2015.08.088","article-title":"Lipid-polyethylene glycol based nano-ocular formulation of ketoconazole","volume":"495","author":"Kakkar","year":"2015","journal-title":"Int. J. Pharm."},{"issue":"6","key":"10.1016\/j.ijpharm.2017.06.042_bib0130","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1089\/10807680152729248","article-title":"Ocular bioavailability of ciprofloxacin in sustained release formulations","volume":"17","author":"Ke","year":"2001","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.ijpharm.2017.06.042_bib0135","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.preteyeres.2013.04.001","article-title":"Nanomedicines for back of the eye drug delivery, gene delivery, and imaging","volume":"36","author":"Kompella","year":"2013","journal-title":"Prog. Retin. Eye Res."},{"issue":"1","key":"10.1016\/j.ijpharm.2017.06.042_bib0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ajps.2013.07.001","article-title":"The endocytosis and intracellular fate of nanomedicines: implication for rational design","volume":"8","author":"Kou","year":"2013","journal-title":"Asian J. Pharm. Sci."},{"issue":"10","key":"10.1016\/j.ijpharm.2017.06.042_bib0145","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1007\/s11095-012-0958-3","article-title":"Effects of particle size and surface modification on cellular uptake and biodistribution of polymeric nanoparticles for drug delivery","volume":"30","author":"Kulkarni","year":"2013","journal-title":"Pharm. Res."},{"issue":"3\u20134","key":"10.1016\/j.ijpharm.2017.06.042_bib0150","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.progpolymsci.2012.07.006","article-title":"Current drug research on PEGylation with small molecular agents","volume":"38","author":"Li","year":"2013","journal-title":"Prog. Polym. Sci."},{"issue":"1","key":"10.1016\/j.ijpharm.2017.06.042_bib0155","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jconrel.2012.06.002","article-title":"Improvement of drug safety by the use of lipid-based nanocarriers","volume":"163","author":"Lim","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2017.06.042_bib0160","first-page":"1","article-title":"Comparison of the results of measurements of the sizes of nanoparticles in stable colloidal solutions by the methods of acoustic spectroscopy dynamic light scattering, and transmission electron microscopy","author":"Lizunova","year":"2017","journal-title":"Meas. Tech."},{"issue":"Suppl","key":"10.1016\/j.ijpharm.2017.06.042_bib0165","doi-asserted-by":"crossref","first-page":"S131","DOI":"10.1016\/S0169-409X(02)00118-7","article-title":"Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations","volume":"54","author":"M\u00fcller","year":"2002","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"3","key":"10.1016\/j.ijpharm.2017.06.042_bib0170","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.ejpb.2008.11.010","article-title":"Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect","volume":"71","author":"Maeda","year":"2009","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"4","key":"10.1016\/j.ijpharm.2017.06.042_bib0175","first-page":"595","article-title":"Lipid-based colloidal carriers for peptide and protein delivery\u2013liposomes versus lipid nanoparticles","volume":"2","author":"Martins","year":"2007","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.ijpharm.2017.06.042_bib0180","unstructured":"A.K. Mishra, Thermoprotected compositions and process for terminal steam sterilization of microparticle preparations Google Patents; 2013."},{"issue":"6","key":"10.1016\/j.ijpharm.2017.06.042_bib0185","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1128\/AAC.44.6.1674-1679.2000","article-title":"Pharmacokinetics of ciprofloxacin in the human eye: a clinical study and population pharmacokinetic analysis","volume":"44","author":"Morlet","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"issue":"2","key":"10.1016\/j.ijpharm.2017.06.042_bib0190","doi-asserted-by":"crossref","first-page":"47","DOI":"10.5497\/wjp.v2.i2.47","article-title":"Ocular drug delivery systems: an overview","volume":"2","author":"Patel","year":"2013","journal-title":"World J. Pharmacol."},{"issue":"5","key":"10.1016\/j.ijpharm.2017.06.042_bib0195","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1039\/c3nr05559k","article-title":"Effect of polyethyleneglycol (PEG) chain length on the bio-nano-interactions between PEGylated lipid nanoparticles and biological fluids: from nanostructure to uptake in cancer cells","volume":"6","author":"Pozzi","year":"2014","journal-title":"Nanoscale"},{"issue":"4","key":"10.1016\/j.ijpharm.2017.06.042_bib0200","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1023\/B:PHAM.0000022411.47059.76","article-title":"The characteristics and mechanisms of uptake of PLGA nanoparticles in rabbit conjunctival epithelial cell layers","volume":"21","author":"Qaddoumi","year":"2004","journal-title":"Pharm. Res."},{"issue":"4","key":"10.1016\/j.ijpharm.2017.06.042_bib0205","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.1167\/iovs.13-13707","article-title":"Drug and gene delivery to the back of the eye: from bench to bedside","volume":"55","author":"Rowe-Rendleman","year":"2014","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"1 Pt A","key":"10.1016\/j.ijpharm.2017.06.042_bib0210","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.bbagen.2015.09.012","article-title":"Using solution X-ray scattering to determine the high-resolution structure and morphology of PEGylated liposomal doxorubicin nanodrugs","volume":"1860","author":"Schilt","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"issue":"5","key":"10.1016\/j.ijpharm.2017.06.042_bib0215","first-page":"224","article-title":"Novel encapsulation of lycopene in niosomes and assessment of its anticancer activity","volume":"8","author":"Sharma","year":"2016","journal-title":"J. Bioequivalence Bioavailab."},{"issue":"7","key":"10.1016\/j.ijpharm.2017.06.042_bib0220","first-page":"5268","article-title":"Formulation and evaluation of topical gel of acelofenac containing piparine","volume":"3","author":"Singh","year":"2013","journal-title":"Indo-Am. J. Pharm. Res."},{"issue":"3","key":"10.1016\/j.ijpharm.2017.06.042_bib0225","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jsps.2013.07.003","article-title":"Design of liposomal colloidal systems for ocular delivery of ciprofloxacin","volume":"22","author":"Taha","year":"2014","journal-title":"Saudi Pharm. J."},{"key":"10.1016\/j.ijpharm.2017.06.042_bib0230","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.molliq.2014.09.021","article-title":"Role of Pluronic F127 micelles in enhancing ocular delivery of ciprofloxacin","volume":"199","author":"Taha","year":"2014","journal-title":"J. Mol. Liq."},{"issue":"1\u20132","key":"10.1016\/j.ijpharm.2017.06.042_bib0235","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.ijpharm.2011.05.044","article-title":"Nanostructured lipid carrier versus solid lipid nanoparticles of simvastatin: comparative analysis of characteristics, pharmacokinetics and tissue uptake","volume":"415","author":"Tiwari","year":"2011","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.ijpharm.2017.06.042_bib0240","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jconrel.2010.03.008","article-title":"Sialic acid and glycopeptides conjugated PLGA nanoparticles for central nervous system targeting: in vivo pharmacological evidence and biodistribution","volume":"145","author":"Tosi","year":"2010","journal-title":"J. Control. Release"},{"issue":"3","key":"10.1016\/j.ijpharm.2017.06.042_bib0245","doi-asserted-by":"crossref","first-page":"035009","DOI":"10.1088\/1468-6996\/15\/3\/035009","article-title":"Intermethod comparison of the particle size distributions of colloidal silica nanoparticles","volume":"15","author":"Tuoriniemi","year":"2014","journal-title":"Sci. Technol. Adv. Mater."},{"issue":"3","key":"10.1016\/j.ijpharm.2017.06.042_bib0250","first-page":"289","article-title":"Importance of solid lipid nanoparticles (SLN) in various administration routes and future perspectives","volume":"2","author":"Uner","year":"2007","journal-title":"Int. J. Nanomed."},{"issue":"4","key":"10.1016\/j.ijpharm.2017.06.042_bib0255","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.nano.2009.02.005","article-title":"Nanoparticles as drug delivery agents specific for CNS: in vivo biodistribution","volume":"5","author":"Vergoni","year":"2009","journal-title":"Nanomedicine"},{"issue":"6","key":"10.1016\/j.ijpharm.2017.06.042_bib0260","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s13346-013-0176-5","article-title":"Questioning the use of PEGylation for drug delivery","volume":"3","author":"Verhoef","year":"2013","journal-title":"Drug Deliv. Transl. Res."},{"issue":"5","key":"10.1016\/j.ijpharm.2017.06.042_bib0265","doi-asserted-by":"crossref","first-page":"315","DOI":"10.2165\/00063030-200822050-00004","article-title":"The impact of PEGylation on biological therapies","volume":"22","author":"Veronese","year":"2008","journal-title":"BioDrugs"},{"issue":"21","key":"10.1016\/j.ijpharm.2017.06.042_bib0270","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/S1359-6446(05)03575-0","article-title":"PEGylation, successful approach to drug delivery","volume":"10","author":"Veronese","year":"2005","journal-title":"Drug Discov. Today"},{"issue":"1","key":"10.1016\/j.ijpharm.2017.06.042_bib0275","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1477-3155-8-22","article-title":"Development of PEGylated PLGA nanoparticle for controlled and sustained drug delivery in cystic fibrosis","volume":"8","author":"Vij","year":"2010","journal-title":"J. Nanobiotechnol."},{"issue":"5","key":"10.1016\/j.ijpharm.2017.06.042_bib0280","doi-asserted-by":"crossref","first-page":"397","DOI":"10.3109\/10611869408996815","article-title":"Sterically stabilized liposomes: physical and biological properties","volume":"2","author":"Woodle","year":"1994","journal-title":"J. Drug Target."},{"issue":"2","key":"10.1016\/j.ijpharm.2017.06.042_bib0285","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0169-409X(95)00028-6","article-title":"Sterically stabilized liposome therapeutics","volume":"16","author":"Woodle","year":"1995","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"2","key":"10.1016\/j.ijpharm.2017.06.042_bib0290","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1089\/jop.2015.0047","article-title":"Recent advances in topical ocular drug delivery","volume":"32","author":"Yellepeddi","year":"2016","journal-title":"J. Ocul. Pharmacol. Ther."},{"issue":"5","key":"10.1016\/j.ijpharm.2017.06.042_bib0295","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s40005-013-0087-y","article-title":"Solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs): recent advances in drug delivery","volume":"43","author":"Yoon","year":"2013","journal-title":"J. Pharm. Investig."},{"issue":"1\u20132","key":"10.1016\/j.ijpharm.2017.06.042_bib0300","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ijpharm.2011.12.058","article-title":"Preparation and characterization of paclitaxel-loaded DSPE-PEG-liquid crystalline nanoparticles (LCNPs) for improved bioavailability","volume":"424","author":"Zeng","year":"2012","journal-title":"Int. J. Pharm."},{"issue":"8","key":"10.1016\/j.ijpharm.2017.06.042_bib0305","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1007\/s11095-014-1320-8","article-title":"Targeted paclitaxel delivery to tumors using cleavable PEG-conjugated solid lipid nanoparticles","volume":"31","author":"Zheng","year":"2014","journal-title":"Pharm. Res."}],"container-title":["International Journal of Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517317305501?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517317305501?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,31]],"date-time":"2018-08-31T19:53:03Z","timestamp":1535745183000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378517317305501"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":61,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["S0378517317305501"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpharm.2017.06.042","relation":{},"ISSN":["0378-5173"],"issn-type":[{"value":"0378-5173","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ocular disposition of ciprofloxacin from topical, PEGylated nanostructured lipid carriers: Effect of molecular weight and density of poly (ethylene) glycol","name":"articletitle","label":"Article Title"},{"value":"International Journal of Pharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpharm.2017.06.042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}